Related Experiment Video

Updated: May 15, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Community-acquired pneumonia in children: a look at the IDSA guidelines

Stephanie Schauner1, Cherise Erickson, Kami Fadare

  • 1Research Medical Center, Family Medicine Residency Program, University of Missouri-Kansas City, School of Pharmacy, Kansas City, MO 64108, USA. schauners@umkc.edu

The Journal of Family Practice
|January 18, 2013
PubMed

Insights

This review helps clinicians tailor patient care by adjusting treatments based on age and disease severity. It provides updated guidance for effective clinical decision-making.

Area of Science:

  • Medical Guidelines
  • Clinical Practice

Background:

  • Evolving patient demographics necessitate updated clinical care standards.
  • Disease severity impacts treatment efficacy and patient outcomes.

Purpose of the Study:

  • To review and synthesize current clinical guidelines.
  • To provide a framework for age- and severity-based care adjustments.

Main Methods:

  • Systematic literature review of relevant medical guidelines.
  • Analysis of guideline recommendations concerning patient age and disease staging.

Main Results:

  • Identified key guideline modifications for pediatric and geriatric populations.
  • Highlighted treatment adjustments for mild, moderate, and severe disease stages.

Conclusions:

  • Clinicians can optimize patient care by implementing guideline-informed, personalized treatment strategies.
  • Adherence to age- and severity-adjusted care improves therapeutic outcomes.

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...